FINWIRES · TerminalLIVE
FINWIRES

CSPC Innovation Pharma Subsidiary Gets FDA Clinical Trial Approval for CRB-701 Cancer Drug; Shares Slide 4%

By

CSPC Innovation Pharmaceutical (SHE:300765) subsidiary CSPC Jushi Biopharmaceutical received U.S. Food and Drug Administration clinical trial approval for its CRB-701 drug, according to a Wednesday after-hours filing with the Shenzhen Stock Exchange.

The drug received approval for its TEMPO-1 randomized controlled clinical trial for the drug targeting Nectin-4, an antigen expressed in urothelial carcinoma as well as in cervical cancer and head and neck squamous cell carcinoma.

Shares fell 4% during afternoon trading on Thursday.

Related Articles

Asia

Tamron Receives Acquisition Proposal From Sony Group

Tamron (TYO:7740) has received a nonbonding acquisition proposal from Sony Group (TYO:6758), according to a Thursday release.The proposal involves a series of transactions that will make the camera lens maker Sony's wholly owned subsidiary.Tamron has created a special committee to review options relating to the proposal.

TYO:6758TYO:7740
Asia

Japan's ANA Holdings Orders Eight Additional Embraer E190-E2 Aircraft

ANA Holdings (TYO:9202) plans to order eight additional Embraer E190-E2 aircraft, expanding on its previous order of 20 aircraft announced in February 2025, according to a company release on Wednesday.The board approved the decision during a meeting on Wednesday.The 100-seat aircraft, featuring PW1900G engines and a range of 5,278 kilometers, aim to improve fuel efficiency, lower noise and operating costs, the release said.

TYO:9202
Asia

United Microelectronics Board OKs Up to NT$1.7 Billion Investment in Private Equity Fund

United Microelectronics (TPE:2303) board approved an investment of up to NT$1.7 billion in private equity fund TGVest Asia Partners III (Taiwan), according to a Wednesday Taiwan Exchange filing.The investment will be made through capital contributions based on capital call notices under the fund's limited partnership agreement.The funds will be used as a long-term investment, it said.

TPE:2303